181 related articles for article (PubMed ID: 8971088)
1. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
Nyengaard JR; Chang K; Berhorst S; Reiser KM; Williamson JR; Tilton RG
Diabetes; 1997 Jan; 46(1):94-106. PubMed ID: 8971088
[TBL] [Abstract][Full Text] [Related]
2. Dietary myo-inositol supplementation does not prevent retinal and glomerular vascular structural changes in chronically diabetic rats.
Tilton RG; Faller AM; LaRose LS; Burgan J; Williamson JR
J Diabetes Complications; 1993; 7(3):188-98. PubMed ID: 8343613
[TBL] [Abstract][Full Text] [Related]
3. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
[TBL] [Abstract][Full Text] [Related]
5. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
Soulis-Liparota T; Cooper ME; Dunlop M; Jerums G
Diabetologia; 1995 Apr; 38(4):387-94. PubMed ID: 7796978
[TBL] [Abstract][Full Text] [Related]
6. Effect of a low protein diet on the relationship of nonenzymatic glycation to altered renal structure and function in diabetes mellitus.
Copeland KR; Yatscoff RW; Thliveris JA; Penner SB; Mehta A
J Diabet Complications; 1989; 3(2):113-9. PubMed ID: 2526137
[TBL] [Abstract][Full Text] [Related]
7. Interactions between hypertension and diabetes on vascular function and structure in rats.
Tilton RG; Pugliese G; Faller AM; LaRose LS; Province MA; Williamson JR
J Diabetes Complications; 1992; 6(3):187-96. PubMed ID: 1472745
[TBL] [Abstract][Full Text] [Related]
8. L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats.
Jyothirmayi GN; Modak R; Reddi AS
Nephron; 2001 Feb; 87(2):148-54. PubMed ID: 11244310
[TBL] [Abstract][Full Text] [Related]
9. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
12. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.
Soulis-Liparota T; Cooper M; Papazoglou D; Clarke B; Jerums G
Diabetes; 1991 Oct; 40(10):1328-34. PubMed ID: 1834497
[TBL] [Abstract][Full Text] [Related]
13. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.
Osicka TM; Yu Y; Panagiotopoulos S; Clavant SP; Kiriazis Z; Pike RN; Pratt LM; Russo LM; Kemp BE; Comper WD; Jerums G
Diabetes; 2000 Jan; 49(1):87-93. PubMed ID: 10615954
[TBL] [Abstract][Full Text] [Related]
14. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
[TBL] [Abstract][Full Text] [Related]
15. Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus.
Ellis EN; Good BH
Metabolism; 1991 Oct; 40(10):1016-9. PubMed ID: 1943726
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats.
Huijberts MS; Wolffenbuttel BH; Crijns FR; Nieuwenhuijzen Kruseman AC; Bemelmans MH; Struijker Boudier HA
Diabetologia; 1994 Jan; 37(1):10-4. PubMed ID: 8150221
[TBL] [Abstract][Full Text] [Related]
17. Effects of aminoguanidine on serum advanced glycation endproducts, urinary albilmin excretion, mesangial expansion, and glomerular basement membrane thickening in Otsuka Long-Evans Tokushima fatty rats.
Yamauchi A; Takei I; Makita Z; Nakamoto S; Ohashi N; Kiguchi H; Ishii T; Koike T; Saruta T
Diabetes Res Clin Pract; 1997 Jan; 34(3):127-33. PubMed ID: 9069563
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats.
Itakura M; Yoshikawa H; Bannai C; Kato M; Kunika K; Kawakami Y; Yamaoka T; Yamashita K
Life Sci; 1991; 49(12):889-97. PubMed ID: 1875797
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.
Hammes HP; Ali SS; Uhlmann M; Weiss A; Federlin K; Geisen K; Brownlee M
Diabetologia; 1995 Mar; 38(3):269-73. PubMed ID: 7758871
[TBL] [Abstract][Full Text] [Related]
20. N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
Schwedler SB; Verbeke P; Bakala H; Weiss MF; Vilar J; Depreux P; Fourmaintraux E; Striker LJ; Striker GE
Diabetes Obes Metab; 2001 Aug; 3(4):230-9. PubMed ID: 11520302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
